T1	tradename 112 120	SOMAVERT
T2	tradename 182 201	SOMAVERT. SOMAVERT
T3	nanoparticle 203 215	pegvisomant)
T4	routeofadministration 235 247	subcutaneous
T5	fdaapprovaldate 275 279	2003
T6	tradename 497 497	
T7	indication 569 579	acromegaly
T8	dose 888 893	40 mg
T9	routeofadministration 907 921	subcutaneously
T10	frequency 1060 1065	daily
T11	routeofadministration 1066 1078	subcutaneous
T12	dose 1093 1098	10 mg
T13	indication 1327 1337	acromegaly
T14	dose 1371 1382	10 to 30 mg
T15	frequency 1383 1393	once daily
T16	tradename 1526 1534	SOMAVERT
T17	tradename 2063 2071	SOMAVERT
T18	adversereaction 2209 2303	infection, pain, nausea, diarrhea, abnormal liver tests, flu syndrome, injection site reaction
T19	company 2356 2362	Pfizer
T20	indication 2609 2619	acromegaly
T21	tradename 2810 2818	SOMAVERT
T22	tradename 4271 4279	SOMAVERT
T23	indication 4314 4324	acromegaly
T24	tradename 4629 4637	SOMAVERT
T25	dose 4641 4646	40 mg
T26	routeofadministration 4653 4668	subcutaneously,
T27	routeofadministration 4735 4747	subcutaneous
T28	frequency 4820 4830	once daily
T29	routeofadministration 4831 4843	subcutaneous
T30	frequency 4947 4952	daily
T31	routeofadministration 4953 4965	subcutaneous
T32	dose 4980 4985	10 mg
T33	tradename 4989 4998	SOMAVERT.
T34	indication 5227 5238	acromegaly.
T35	tradename 5371 5379	SOMAVERT
T36	dose 5651 5662	10 to 30 mg
T37	routeofadministration 5669 5683	subcutaneously
T38	frequency 5684 5694	once daily
T39	dose 5727 5732	30 mg
T40	routeofadministration 5739 5753	subcutaneously
T41	frequency 5754 5765	once daily.
T42	tradename 5813 5821	SOMAVERT
T43	tradename 5845 5854	SOMAVERT,
T44	tradename 6104 6112	SOMAVERT
T45	tradename 6202 6211	SOMAVERT,
T46	dose 6392 6397	40 mg
T47	tradename 6495 6503	SOMAVERT
T48	dose 6515 6520	20 mg
T49	nanoparticle 6524 6535	pegvisomant
T50	dose 6638 6643	40 mg
T51	tradename 6726 6734	SOMAVERT
T52	tradename 7143 7151	SOMAVERT
T53	dose 7163 7168	20 mg
T54	nanoparticle 7172 7183	pegvisomant
T55	tradename 7446 7455	SOMAVERT.
T56	nanoparticle 7595 7606	pegvisomant
T57	tradename 7743 7751	SOMAVERT
T58	tradename 7880 7888	SOMAVERT
T59	dose 8096 8101	20 mg
T60	nanoparticle 8105 8116	pegvisomant
T61	tradename 8175 8183	SOMAVERT
T62	tradename 8300 8308	SOMAVERT
T63	routeofadministration 8329 8343	subcutaneously
T64	tradename 8489 8497	Somavert
T65	dose 8506 8511	20mg.
T66	tradename 8557 8565	SOMAVERT
T67	routeofadministration 8587 8601	subcutaneously
T68	frequency 8854 8859	daily
T69	dose 8867 8879	10 to 30 mg)
T70	tradename 9009 9017	SOMAVERT
T71	dose 9029 9044	10, 15 or 20 mg
T72	nanoparticle 9048 9059	pegvisomant
T73	tradename 9328 9337	SOMAVERT.
T74	nanoparticle 9476 9487	pegvisomant
T75	tradename 9624 9632	SOMAVERT
T76	tradename 9764 9772	SOMAVERT
T77	dose 9980 9995	10, 15 or 20 mg
T78	nanoparticle 9999 10010	pegvisomant
T79	tradename 10069 10077	SOMAVERT
T80	tradename 10186 10194	SOMAVERT
T81	routeofadministration 10204 10218	subcutaneously
T82	frequency 10316 10321	daily
T83	dose 10332 10343	25 or 30 mg
T84	tradename 10401 10409	Somavert
T85	dose 10442 10454	25 or 30 mg.
T86	frequency 10473 10478	daily
T87	dose 10489 10501	25 or 30 mg,
T88	tradename 10534 10542	SOMAVERT
T89	routeofadministration 10552 10566	subcutaneously
T90	tradename 11309 11318	SOMAVERT.
T91	tradename 11699 11708	SOMAVERT.
T92	tradename 11778 11787	SOMAVERT,
T93	tradename 12161 12169	SOMAVERT
T94	tradename 12291 12299	Somavert
T95	tradename 12556 12564	SOMAVERT
T96	tradename 12626 12634	SOMAVERT
T97	tradename 12714 12723	SOMAVERT.
T98	tradename 12943 12952	SOMAVERT;
T99	tradename 13126 13134	SOMAVERT
T100	tradename 13446 13455	SOMAVERT.
T101	tradename 13661 13670	SOMAVERT,
T102	tradename 13802 13810	SOMAVERT
T103	tradename 14043 14052	SOMAVERT.
T104	tradename 14455 14463	SOMAVERT
T105	tradename 14764 14773	SOMAVERT,
T106	tradename 15173 15181	SOMAVERT
T107	tradename 15376 15384	SOMAVERT
T108	indication 15486 15497	acromegaly,
T109	adversereaction 15762 15777	Lipohypertrophy
T110	adversereaction 15804 15819	lipohypertrophy
T111	tradename 15845 15854	SOMAVERT.
T112	adversereaction 15938 15968	injection site lipohypertrophy
T113	dose 16001 16006	10 mg
T114	frequency 16006 16011	/day.
T115	dose 16154 16159	10 mg
T116	frequency 16159 16164	/day,
T117	adversereaction 16179 16195	lipohypertrophy.
T118	adversereaction 16348 16363	lipohypertrophy
T119	adversereaction 16411 16436	Systemic Hypersensitivity
T120	adversereaction 16455 16491	systemic hypersensitivity reactions,
T121	tradename 16560 16568	Somavert
T122	adversereaction 17008 17023	Lipohypertrophy
T123	adversereaction 17071 17096	Systemic hypersensitivity
T124	tradename 17264 17272	SOMAVERT
T125	tradename 17341 17350	SOMAVERT,
T126	tradename 17991 17999	SOMAVERT
T127	tradename 18543 18551	SOMAVERT
T128	indication 18569 18580	acromegaly,
T129	tradename 18635 18643	SOMAVERT
T130	frequency 18644 18654	once daily
T131	tradename 18724 18733	Somavert)
T132	indication 19008 19018	acromegaly
T133	adversereaction 19133 19157	transaminase elevations,
T134	adversereaction 19175 19214	lipohypertrophy at the injection sites,
T135	adversereaction 19236 19260	substantial weight gain.
T136	tradename 19421 19429	SOMAVERT
T137	indication 19603 19614	Acromegaly*
T138	tradename 19631 19639	SOMAVERT
T139	dose 19640 19645	10 mg
T140	frequency 19645 19649	/day
T141	dose 19656 19661	15 mg
T142	frequency 19661 19665	/day
T143	dose 19672 19677	20 mg
T144	frequency 19677 19681	/day
T145	adversereaction 19688 19705	Infection&#x20ac;
T146	adversereaction 19725 19729	Pain
T147	adversereaction 19759 19765	Nausea
T148	adversereaction 19790 19798	Diarrhea
T149	adversereaction 19823 19852	Abnormal liver function tests
T150	adversereaction 19882 19894	Flu syndrome
T151	adversereaction 19919 19942	Injection site reaction
T152	adversereaction 19967 19976	Dizziness
T153	adversereaction 20005 20022	Accidental injury
T154	adversereaction 20046 20055	Back pain
T155	adversereaction 20079 20088	Sinusitis
T156	adversereaction 20112 20122	Chest pain
T157	adversereaction 20141 20157	Peripheral edema
T158	adversereaction 20176 20188	Hypertension
T159	adversereaction 20202 20213	Paresthesia
T160	tradename 20361 20369	SOMAVERT
T161	tradename 20477 20485	SOMAVERT
T162	dose 20486 20491	10 mg
T163	adversereaction 20509 20522	cold symptoms
T164	adversereaction 20528 20555	upper respiratory infection
T165	adversereaction 20561 20568	blister
T166	adversereaction 20578 20591	ear infection
T167	adversereaction 20647 20660	cold symptoms
T168	adversereaction 20669 20684	chest infection
T169	tradename 20771 20787	SOMAVERT-treated
T170	tradename 20938 20947	SOMAVERT,
T171	tradename 21108 21117	SOMAVERT.
T172	tradename 21231 21240	SOMAVERT.
T173	tradename 21625 21633	SOMAVERT
T174	tradename 21954 21963	SOMAVERT.
T175	adversereaction 22167 22202	Systemic hypersensitivity reactions
T176	adversereaction 22213 22262	anaphylactic reactions, laryngospasm, angioedema,
T177	adversereaction 22291 22327	rash, erythema, pruritus, urticaria)
T178	indication 22536 22546	Acromegaly
T179	tradename 22560 22568	SOMAVERT
T180	indication 22675 22685	acromegaly
T181	tradename 22699 22708	SOMAVERT,
T182	tradename 23193 23201	SOMAVERT
T183	tradename 23233 23241	SOMAVERT
T184	indication 23258 23269	acromegaly.
T185	adversereaction 23428 23443	Lipohypertrophy
T186	tradename 24390 24399	SOMAVERT,
T187	indication 24414 24424	acromegaly
T188	tradename 24688 24696	SOMAVERT
T189	nanoparticle 25060 25071	pegvisomant
T190	routeofadministration 25075 25087	subcutaneous
T191	dose 25097 25115	1, 3, and 10 mg/kg
T192	frequency 25115 25120	/day.
T193	nanoparticle 25182 25193	pegvisomant
T194	dose 25233 25241	10mg/kg/
T195	frequency 25241 25244	day
T196	tradename 25494 25502	SOMAVERT
T197	nanoparticle 25605 25616	pegvisomant
T198	tradename 25718 25726	SOMAVERT
T199	tradename 25815 25823	SOMAVERT
T200	tradename 25913 25921	SOMAVERT
T201	tradename 26334 26342	SOMAVERT
T202	tradename 26624 26632	SOMAVERT
T203	dose 26700 26705	80 mg
T204	frequency 26705 26709	/day
T205	tradename 26968 26976	SOMAVERT
T206	tradename 27096 27104	SOMAVERT
T207	nanoparticle 27114 27126	pegvisomant,
T208	nanoparticle 27238 27249	Pegvisomant
T209	activeingredient 27255 27323	protein of recombinant DNA origin containing 191 amino acid residues
T210	surfacecoating 27341 27366	polyethylene glycol (PEG)
T211	surfacecoating 27419 27423	PEG/
T212	nanoparticle 27481 27492	pegvisomant
T213	molecularweight 27496 27511	21,998 Daltons.
T214	surfacecoating 27540 27543	PEG
T215	nanoparticle 27555 27566	pegvisomant
T216	molecularweight 27584 27597	5000 Daltons.
T217	nanoparticle 27635 27646	pegvisomant
T218	molecularweight 27670 27705	42,000, 47,000, and 52,000 Daltons.
T219	nanoparticle 27757 27768	pegvisomant
T220	surfacecoating 27778 27790	PEG polymers
T221	nanoparticle 27852 27863	Pegvisomant
T222	tradename 28122 28130	Somavert
T223	surfacecoating 28340 28343	PEG
T224	nanoparticle 28489 28501	pegvisomant,
T225	nanoparticle 28687 28698	Pegvisomant
T226	tradename 28852 28860	SOMAVERT
T227	routeofadministration 28939 28951	subcutaneous
T228	tradename 29025 29033	SOMAVERT
T229	nanoparticle 29107 29118	pegvisomant
T230	inactiveingredient 29219 29227	glycine,
T231	inactiveingredient 29239 29248	mannitol,
T232	inactiveingredient 29260 29295	sodium phosphate dibasic anhydrous,
T233	inactiveingredient 29311 29350	sodium phosphate monobasic monohydrate.
T234	tradename 29352 29360	SOMAVERT
T235	nanoparticle 29710 29721	Pegvisomant
T236	nanoparticle 30153 30164	Pegvisomant
T237	nanoparticle 30290 30301	Pegvisomant
T238	routeofadministration 30611 30623	subcutaneous
T239	nanoparticle 30651 30662	pegvisomant
T240	tmax 30711 30725	33 to 77 hours
T241	dose 30783 30788	20-mg
T242	routeofadministration 30789 30801	subcutaneous
T243	dose 30830 30835	10-mg
T244	routeofadministration 30836 30847	intravenous
T245	nanoparticle 30913 30924	pegvisomant
T246	volumeofdistribution 30928 30931	7 L
T247	nanoparticle 30980 30991	pegvisomant
T248	routeofadministration 31053 31065	subcutaneous
T249	nanoparticle 31108 31119	pegvisomant
T250	nanoparticle 31187 31198	pegvisomant
T251	frequency 31245 31250	daily
T252	dose 31260 31277	10, 15, and 20 mg
T253	cmax 31283 31332	6600  1330; 16,000  2200; and 27,000  3100 ng/mL,
T254	nanoparticle 31380 31391	pegvisomant
T255	surfacecoating 31427 31446	polyethylene glycol
T256	nanoparticle 31508 31519	pegvisomant
T257	nanoparticle 31631 31642	pegvisomant
T258	clearance 31698 31711	36 to 28 mL/h
T259	routeofadministration 31716 31728	subcutaneous
T260	dose 31748 31759	10 to 20 mg
T261	frequency 31759 31764	/day,
T262	nanoparticle 31792 31803	pegvisomant
T263	nanoparticle 31844 31855	Pegvisomant
T264	plasmahalflife 31920 31934	74 - 172 hours
T265	nanoparticle 32078 32089	pegvisomant
T266	nanoparticle 32215 32226	pegvisomant
T267	nanoparticle 32638 32649	pegvisomant
T268	nanoparticle 32716 32727	pegvisomant
T269	nanoparticle 32882 32893	Pegvisomant
T270	routeofadministration 32911 32925	subcutaneously
T271	frequency 32934 32939	daily
T272	dose 32964 32981	2, 8 and 20 mg/kg
T273	dose 33016 33021	20 mg
T274	nanoparticle 33080 33091	pegvisomant
T275	dose 33095 33109	8 and 20 mg/kg
T276	routeofadministration 33398 33410	subcutaneous
T277	nanoparticle 33436 33447	Pegvisomant
T278	nanoparticle 33761 33772	Pegvisomant
T279	routeofadministration 33863 33875	subcutaneous
T280	dose 33888 33897	10 mg/kg/
T281	frequency 33897 33900	day
T282	indication 34055 34065	acromegaly
T283	tradename 34160 34169	SOMAVERT.
T284	indication 34227 34237	acromegaly
T285	dose 34957 34962	10 mg
T286	frequency 34962 34966	/day
T287	dose 34975 34980	15 mg
T288	frequency 34980 34984	/day
T289	dose 34997 35002	20 mg
T290	frequency 35002 35006	/day
T291	tradename 35017 35025	SOMAVERT
T292	routeofadministration 35026 35045	subcutaneouslyIGF-I
T293	tradename 35182 35190	SOMAVERT
T294	tradename 35427 35435	SOMAVERT
T295	dose 35436 35441	10 mg
T296	frequency 35441 35445	/day
T297	dose 35452 35457	15 mg
T298	frequency 35457 35461	/day
T299	dose 35468 35473	20 mg
T300	frequency 35473 35477	/day
T301	tradename 35647 35655	SOMAVERT
T302	tradename 36023 36031	SOMAVERT
T303	tradename 36447 36455	SOMAVERT
T304	indication 36576 36587	acromegaly.
T305	indication 36635 36645	acromegaly
T306	indication 36861 36871	acromegaly
T307	indication 37206 37216	Acromegaly
T308	tradename 37227 37235	SOMAVERT
T309	dose 37242 37248	10 mg/
T310	frequency 37248 37251	day
T311	dose 37257 37263	15 mg/
T312	frequency 37263 37266	day
T313	dose 37276 37282	20 mg/
T314	frequency 37282 37285	day
T315	indication 37387 37397	acromegaly
T316	nanoparticle 37840 37852	pegvisomant,
T317	tradename 37903 37912	SOMAVERT.
T318	tradename 37997 38005	SOMAVERT
T319	dose 38006 38012	20 mg/
T320	frequency 38012 38016	day.
T321	indication 38158 38168	acromegaly
T322	tradename 38198 38206	SOMAVERT
T323	tradename 38518 38526	SOMAVERT
T324	adversereaction 38905 38965	headaches, elevated liver function tests, pancreatic cancer,
T325	adversereaction 38970 38982	weight gain)
T326	tradename 39156 39164	SOMAVERT
T327	nanoparticle 39166 39178	pegvisomant)
T328	tradename 39247 39255	SOMAVERT
T329	nanoparticle 39257 39269	pegvisomant)
T330	tradename 39527 39535	SOMAVERT
T331	tradename 39811 39819	SOMAVERT
T332	tradename 40125 40134	SOMAVERT:
T333	tradename 40157 40165	SOMAVERT
T334	tradename 40190 40198	SOMAVERT
T335	tradename 40329 40337	SOMAVERT
T336	tradename 40359 40367	SOMAVERT
T337	tradename 40430 40438	SOMAVERT
T338	tradename 40617 40625	SOMAVERT
T339	tradename 41059 41068	SOMAVERT.
T340	indication 41234 41244	acromegaly
T341	tradename 41624 41633	SOMAVERT.
T342	tradename 41688 41696	SOMAVERT
T343	tradename 41767 41775	SOMAVERT
T344	tradename 42305 42313	SOMAVERT
T345	tradename 42586 42594	SOMAVERT
T346	nanoparticle 42609 42620	pegvisomant
T347	tradename 42644 42663	SOMAVERT? SOMAVERT
T348	indication 42746 42757	acromegaly)
T349	tradename 42759 42767	SOMAVERT
T350	tradename 42900 42908	SOMAVERT
T351	tradename 43000 43009	SOMAVERT?
T352	tradename 43026 43035	SOMAVERT,
T353	nanoparticle 43101 43112	pegvisomant
T354	tradename 43142 43151	SOMAVERT.
T355	tradename 43164 43172	SOMAVERT
T356	nanoparticle 43196 43207	pegvisomant
T357	tradename 43237 43246	SOMAVERT.
T358	tradename 43313 43322	SOMAVERT.
T359	tradename 43461 43469	SOMAVERT
T360	tradename 43563 43572	SOMAVERT.
T361	tradename 43644 43652	SOMAVERT
T362	tradename 43748 43756	SOMAVERT
T363	tradename 43927 43935	SOMAVERT
T364	tradename 44012 44020	SOMAVERT
T365	tradename 44233 44241	SOMAVERT
T366	tradename 44676 44685	SOMAVERT?
T367	tradename 44809 44818	SOMAVERT.
T368	tradename 44980 44989	SOMAVERT.
T369	tradename 45047 45056	SOMAVERT.
T370	tradename 45068 45076	SOMAVERT
T371	frequency 45086 45101	1 time each day
T372	routeofadministration 45135 45148	subcutaneous)
T373	tradename 45339 45347	SOMAVERT
T374	tradename 45473 45482	SOMAVERT.
T375	tradename 45514 45523	SOMAVERT,
T376	tradename 45599 45608	SOMAVERT,
T377	tradename 45800 45819	SOMAVERT? SOMAVERT
T378	tradename 45991 46000	SOMAVERT.
T379	tradename 46043 46051	SOMAVERT
T380	tradename 46939 46947	SOMAVERT
T381	tradename 47259 47268	SOMAVERT.
T382	tradename 47568 47577	SOMAVERT?
T383	tradename 47608 47616	SOMAVERT
T384	tradename 47649 47657	SOMAVERT
T385	tradename 47725 47734	SOMAVERT.
T386	tradename 47764 47772	SOMAVERT
T387	tradename 47810 47818	SOMAVERT
T388	tradename 47885 47893	SOMAVERT
T389	tradename 47986 47994	SOMAVERT
T390	tradename 48063 48071	SOMAVERT
T391	tradename 48099 48107	SOMAVERT
T392	tradename 48120 48128	SOMAVERT
T393	tradename 48234 48243	SOMAVERT.
T394	tradename 48362 48370	SOMAVERT
T395	tradename 48585 48593	SOMAVERT
T396	tradename 48755 48764	SOMAVERT.
T397	tradename 48912 48920	SOMAVERT
T398	tradename 49062 49071	SOMAVERT?
T399	nanoparticle 49092 49104	pegvisomant,
T400	surfacecoating 49115 49134	polyethylene glycol
T401	inactiveingredient 49158 49212	glycine, mannitol, sodium phosphate dibasic anhydrous,
T402	inactiveingredient 49217 49255	sodium phosphate monobasic monohydrate
T403	tradename 49279 49287	SOMAVERT
T404	nanoparticle 49303 49314	pegvisomant
T405	tradename 49347 49355	SOMAVERT
T406	routeofadministration 49388 49401	subcutaneous)
T407	tradename 49431 49439	SOMAVERT
T408	tradename 49589 49598	SOMAVERT.
T409	tradename 49637 49645	SOMAVERT
T410	tradename 49683 49691	SOMAVERT
T411	tradename 49847 49855	SOMAVERT
T412	tradename 49919 49927	SOMAVERT
T413	tradename 50674 50682	SOMAVERT
T414	tradename 50697 50705	SOMAVERT
T415	tradename 50753 50762	SOMAVERT,
T416	tradename 50834 50842	SOMAVERT
T417	tradename 50952 50960	SOMAVERT
T418	tradename 50990 50998	SOMAVERT
T419	tradename 51069 51077	SOMAVERT
T420	tradename 51146 51154	SOMAVERT
T421	tradename 51174 51182	SOMAVERT
T422	tradename 53541 53550	SOMAVERT.
T423	tradename 53669 53677	SOMAVERT
T424	tradename 54182 54190	SOMAVERT
T425	tradename 54889 54897	SOMAVERT
T426	tradename 55068 55077	SOMAVERT.
T427	tradename 55148 55156	SOMAVERT
T428	tradename 55226 55234	SOMAVERT
T429	tradename 56716 56724	SOMAVERT
T430	tradename 57054 57062	SOMAVERT
T431	tradename 57188 57196	SOMAVERT
T432	tradename 57487 57495	SOMAVERT
T433	tradename 57522 57530	SOMAVERT
T434	routeofadministration 57559 57572	subcutaneous)
T435	tradename 58039 58048	SOMAVERT.
T436	tradename 58218 58227	SOMAVERT,
T437	tradename 58292 58300	SOMAVERT
